OneSource Specialty Pharma partners with Formycon AG to provide integrated biologics manufacturing for biosimilars, supporting global healthcare markets.
Read MoreNeeraj Sharma
OneSource Q2FY26: EBITDA Up 37 Per Cent YoY; PAT at INR 449 Million
OneSource Q2FY26 results show 12% revenue growth, 37% EBITDA rise, and 506 bps margin expansion, supported by IP-led business and strategic acquisitions.
Read More